Jeil Pharma Holdings Inc (KRX:002620)

Jeil Pharma Holdings Revenue

Jeil Pharma Holdings had revenue of 150.40B KRW in the quarter ending March 31, 2026, a decrease of -17.38%. This brings the company's revenue in the last twelve months to 625.97B, down -19.02% year-over-year. In the year 2025, Jeil Pharma Holdings had annual revenue of 657.61B, down -15.67%.

• Revenue (ttm): 625.97B
• Revenue Growth: -19.02%
• P/S Ratio: 0.18
• Revenue / Employee: 16.92B
• Employees: 37
• Market Cap: 113.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	657.61B	-122.21B	-15.67%
Dec 31, 2024	779.82B	-24.22B	-3.01%
Dec 31, 2023	804.04B	11.08B	1.40%
Dec 31, 2022	792.96B	30.40B	3.99%
Dec 31, 2021	762.57B	571.30M	0.07%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error